Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Asthenia

Known as: Asthenia NOS, Asthenia [Disease/Finding], Asthenias 
Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
BACKGROUND There is no recommended therapy for malignant pleural mesothelioma that has progressed after first-line pemetrexed and… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
BACKGROUND Dabrafenib, an inhibitor of mutated BRAF, has clinical activity with a manageable safety profile in studies of phase 1… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND The multitargeted tyrosine kinase inhibitor sunitinib has shown activity against pancreatic neuroendocrine tumors in… Expand
  • table 1
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Sipuleucel‐T is an investigational active cellular immunotherapy product designed to stimulate an immune response against… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Vascular endothelial growth factor (VEGF) inhibition is a valid therapeutic approach in renal cell carcinoma… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Interferon alfa is widely used for metastatic renal-cell carcinoma but has limited efficacy and tolerability… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE To evaluate the antitumor activity and toxicity of single-agent cetuximab in patients with chemotherapy-refractory… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
PURPOSE To evaluate the efficacy and safety of first-line, single-agent trastuzumab in women with HER2-overexpressing metastatic… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
  • C. Davis
  • British Journal of Cancer
  • 1994
  • Corpus ID: 12018937
The multi-disciplinary nature of palliative care is emphasized throughout the book. As palliative care has become an established… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
BACKGROUND Amyotrophic lateral sclerosis is a progressive motor neuron disease for which there is no adequate treatment. Some… Expand
Is this relevant?